#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cervix carcinoma recurrent Hepatic angiosarcoma Thyroid cancer metastatic Complex regional pain syndrome Hormone-dependent prostate cancer Synovitis Metastases to central nervous system Acute graft versus host disease in skin Fibrodysplasia ossificans progressiva Immunoglobulin G4 related disease Bronchopulmonary dysplasia Multiple system atrophy Epstein-Barr virus associated lymphoproliferative disorder Malignant oligodendroglioma Scleroderma associated digital ulcer More trials…

    Learn about Rare Diseases

    Malignant fibrous histiocytoma – Life with Disease Marfan’s syndrome – Basic Information Hairy cell leukaemia recurrent – Treatment Lymphangiosarcoma – Basic Information Idiopathic inflammatory myopathy Pemphigus – Treatment Glomerulonephritis rapidly progressive – Basic Information Mucopolysaccharidosis II – Diagnostics Congenital hypotransferrinaemia – Treatment Osteosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    REGN7544 Tucatinib Pemafibrate Omp10 Rp-1664 Sulfate Cetirizine Tofogliflozin Glyceryl Trinitrate Calcium Carbonate Ly3454738 Ripretinib Fluciclovine (18F) Pirtobrutinib Tipapkinogene Sovacivec Minzasolmin Pirfenidone Telitacicept Prax-628 Indacaterol Acetate Ciclosporin More therapies…

    Learn about Your Condition

    Endometrial adenocarcinoma Follicular lymphoma Small intestine carcinoma Neonatal anoxia Atrial fibrillation Thalassaemia Mitochondrial myopathy Vitamin D deficiency Labour induction Prolymphocytic leukaemia Biliary tract disorder Frostbite Apheresis Gender dysphoria Depression More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Colchicine after Electrocardioversion to Prevent Recurrence of Atrial Fibrillation in Adult Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Colchicine
    Germany

  • High‑Flow Oxygen to Reduce Hypoxemia in High‑Risk Adults Undergoing Sedated Gastroscopy, Colonoscopy or Endoscopic Ultrasound

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Oxygen
    Spain

  • Low‑dose human serum albumin versus standard dose during large‑volume paracentesis in patients with liver cirrhosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    The Netherlands

  • Evaluation of Propranolol‑Enhanced Traumatic Memory Reactivation for Post‑Traumatic Stress Disorder in Women Victims of Violence

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Propranolol Hydrochloride
    France

  • Safety and Efficacy Study of FOXP3‑T4 and Aldesleukin in Patients with IPEX Syndrome

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Aldesleukin
    France

  • Effect of serenoa repens on chronic prostate inflammation in men with benign prostatic hyperplasia: a phase III randomized study

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Benign prostatic hyperplasia
    Italy
Previous Page
1 … 689 690 691 692 693 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!